PONTI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.466
EU - Europa 8.526
AS - Asia 6.618
SA - Sud America 1.100
AF - Africa 105
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 12
Totale 37.844
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.070
GB - Regno Unito 3.214
SG - Singapore 2.327
CN - Cina 1.935
IT - Italia 1.781
HK - Hong Kong 999
BR - Brasile 913
SE - Svezia 903
DE - Germania 730
UA - Ucraina 464
VN - Vietnam 437
RU - Federazione Russa 362
FI - Finlandia 354
TR - Turchia 328
CA - Canada 256
FR - Francia 187
BG - Bulgaria 166
KR - Corea 127
MX - Messico 110
ID - Indonesia 103
IN - India 100
AR - Argentina 67
NL - Olanda 64
IE - Irlanda 55
JP - Giappone 54
ZA - Sudafrica 39
EC - Ecuador 37
PL - Polonia 37
BD - Bangladesh 35
ES - Italia 31
IQ - Iraq 27
BE - Belgio 26
LT - Lituania 24
CL - Cile 20
MY - Malesia 18
AT - Austria 17
AE - Emirati Arabi Uniti 16
RO - Romania 16
CH - Svizzera 15
MA - Marocco 15
PY - Paraguay 15
CO - Colombia 14
CZ - Repubblica Ceca 14
EG - Egitto 14
VE - Venezuela 14
KE - Kenya 12
PE - Perù 12
IR - Iran 11
JO - Giordania 11
EU - Europa 10
PK - Pakistan 10
SA - Arabia Saudita 10
AU - Australia 9
HU - Ungheria 9
LU - Lussemburgo 9
NO - Norvegia 8
UZ - Uzbekistan 8
DO - Repubblica Dominicana 7
PA - Panama 7
PH - Filippine 7
PT - Portogallo 7
TH - Thailandia 7
KZ - Kazakistan 6
LB - Libano 6
CR - Costa Rica 5
IL - Israele 5
NG - Nigeria 5
NP - Nepal 5
RS - Serbia 5
AZ - Azerbaigian 4
DK - Danimarca 4
KG - Kirghizistan 4
TN - Tunisia 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AO - Angola 3
BH - Bahrain 3
BO - Bolivia 3
GT - Guatemala 3
NZ - Nuova Zelanda 3
OM - Oman 3
PS - Palestinian Territory 3
SI - Slovenia 3
UY - Uruguay 3
AM - Armenia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
HR - Croazia 2
LV - Lettonia 2
MD - Moldavia 2
MT - Malta 2
NI - Nicaragua 2
SD - Sudan 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
Totale 37.822
Salva come PNG Salva come JPEG
Città #
Fairfield 2.538
Southend 2.473
Santa Clara 1.816
Ashburn 1.677
Woodbridge 1.579
Singapore 1.326
Houston 1.166
Hong Kong 993
Seattle 979
Chandler 923
Wilmington 851
Jacksonville 831
Cambridge 810
Dearborn 786
Ann Arbor 661
Chicago 594
Nyköping 543
Hefei 472
Los Angeles 424
Beijing 419
London 415
Modena 282
Salt Lake City 246
San Diego 207
Princeton 203
Helsinki 199
Ottawa 192
Izmir 188
San Jose 165
Sofia 165
New York 157
Eugene 155
Council Bluffs 147
Ho Chi Minh City 140
The Dalles 130
Tampa 123
Shanghai 119
Seoul 118
Elk Grove Village 115
Milan 108
Rome 105
Buffalo 104
Hanoi 102
Dallas 95
Moscow 94
Jakarta 84
Bremen 81
São Paulo 81
Munich 74
Sterling 71
Lancaster 58
Redwood City 54
Frankfurt am Main 53
Dublin 52
Grafing 51
Columbus 48
Phoenix 46
Dong Ket 44
Guangzhou 38
Miami 36
Bologna 34
Des Moines 34
Norwalk 34
Tokyo 34
Boardman 33
Fremont 33
Denver 32
Warsaw 31
Detroit 30
Orem 30
Rio de Janeiro 29
Atlanta 28
Belo Horizonte 28
Brooklyn 27
Dulles 27
Redondo Beach 24
Dongguan 23
Nanjing 23
Montreal 22
Palermo 22
San Mateo 22
Turin 22
Kunming 21
Turku 21
Curitiba 20
Pittsburgh 20
Changsha 19
Hounslow 19
Stockholm 19
Haiphong 18
Kilburn 18
Brussels 17
Falls Church 17
San Francisco 17
Toronto 17
Boston 16
Chiswick 16
Jersey City 16
New Delhi 16
Parma 16
Totale 27.751
Salva come PNG Salva come JPEG
Nome #
Mutazioni somatiche di BRAF in pazienti affetti da melanoma maligno metastatico ed efficacia clinica degli approcci terapeutici a bersaglio molecolare con inibitori di BRAF 544
Neoplasie maligne e benigne associate al melanoma multiplo: coinvolgimento di MITF, PTEN and CDKN2A nella cancerogenesi melanocitaria multipla. 513
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 411
Reticular grey-blue areas of regression as a dermoscopic marker of melanoma in situ. 407
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 404
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 402
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 401
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 391
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 391
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLD mutation in Brenner tumor 374
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 372
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 372
Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients 370
The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients 369
"Collision" metastasis from unknown primary squamous cell carcinoma and papillary microcarcinoma of thyroid presenting as lateral cervical cystic mass 358
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 354
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 334
Variegated Dermoscopy of in situ Melanoma. 333
Brooke-Spiegler syndrome: Report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes 332
Diagnostic and pathogenetic role of café-au-lait macules in nevoid basal cell carcinoma syndrome 331
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 328
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome. 327
Seminal Cell-Free DNA Assessment as a Novel Prostate Cancer Biomarker 325
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 323
Unicystic ameloblastoma associated with the novel K729M PTCH1 mutation in a patient with nevoid basal cell carcinoma (Gorlin) syndrome. 320
Congenital Glioblastoma multiforme and eruptive disseminated Spitz nevi 320
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 319
A novel CYLD germline mutation in Brooke-Spiegler syndrome. 317
Aetiology of colorectal cancer and relevance of monogenic inheritance. 315
BRAF ,NRASandC-KITAdvanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and Survival 314
PTCH1 germline mutations and the basaloid follicular hamartoma values in the tumor spectrum of basal cell carcinoma syndrome (NBCCS) 313
Grey-blue regression in melanoma in situ-evaluation on 111 cases. 311
Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: A case report 311
Hereditary trichilemmal cysts: a proposal for the assessment of diagnostic clinical criteria 310
Hypomelanosis of Ito with a trisomy 2 mosaicism: a case report 306
Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology 303
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis 303
The impact of histopathologic diagnosis on the proper management of testis neoplasms. 299
Ameloblastoma: A neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome 297
Caso di Neurofibromatosi diagnosticata a 71 anni 293
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 292
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? 291
NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies 290
Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy 289
M09Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 288
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 288
Skeletal and cranio-facial signs in Gorlin syndrome from ancient Egypt to the modern age: Sphenoid asymmetry in a patient with a novel PTCH1 mutation 287
Confocal microscopy characterization of BRAFV600E mutated melanomas 287
Muir-Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients 285
Dermoscopy of small melanomas: just a miniaturized dermoscopy? 283
Biomarkers associated with COVID-19 disease progression 283
Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumors. 281
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 279
High Magnification Digital Dermoscopy of Basal Cell Carcinoma: A Single-centre Study on 400 cases. 277
Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome 273
Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanomas 272
Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes. 270
Seminal cell free DNA concentration levels discriminate between prostate cancer and benign prostatic hyperplasia 270
Desmoplastic melanoma: a challenge for the oncologist 268
Seminal cell-free DNA assessment as a novel prostate cancer biomarker 267
Mismatch Repair Gene Deficiency and Genetic Anticipation in Lynch Syndrome 265
Microsatellite instability and colorectal cancer prognosis. 259
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 256
Multiphoton laser tomography and fluorescence lifetime imaging of melanoma: morphologic features and quantitative data for sensitive and specific non-invasive diagnostics. 256
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 256
Fibroepithelioma of Pinkus: Solitary tumor or sign of a complex gastrointestinal syndrome 251
Role of microsatellite instability, immunohistochemistry and Mismatch Repair germline aberrations in immunosuppressed transplant patients: a phenocopy dilemma in Muir-Torre Syndrome. 249
Can noninvasive imaging tools potentially predict the risk of ulceration in invasive melanomas showing blue and black colors? 249
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 248
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 247
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 246
Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma 245
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 244
Wall paintings facies and their possible genetic correlates in the ancient Pompeii: A bio-anthropologic message from the past? 241
Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 241
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 240
Seminal cell-free DNA molecular profile as a novel diagnostic and prognostic prostate cancer biomarkers 239
The dermoscopic variability of pigment network in melanoma in situ. 235
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 233
Skeletal stigmata as keys to access to the composite and ancient Gorlin-Goltz syndrome history: The Egypt, Pompeii and Herculaneum lessons 233
Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study on 140 cases. 230
Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies 230
Distinctive clinical and dermoscopic features of BRAFp.V600K mutated melanomas. 228
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 227
Stem cell properties in cell cultures from different stage of melanoma progression. 225
Relationship between histological and computer based assessment of melanoma diameter and thickness in head & neck vs. trunk melanoma. 222
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 222
Biological characterization of mucinous carcinoma of the colon and rectum 221
Diagnosis of BCC by multiphoton laser tomography. 219
Erratum: Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanoma (Disease Markers) 219
Microsatellite instability, immunohistochemistry and germline mismatch repair gene mutations for the diagnosis of Muir-Torre syndrome in immunosuppressed patients 218
Clinical utility gene card for: Gorlin syndrome - update 2013. 217
Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non-invasive diagnostics 216
The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations. 216
Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report 208
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. 207
High-resolution imaging of basal cell carcinoma: a comparison between multiphoton microscopy with fluorescence lifetime imaging and reflectance confocal microscopy. 206
Muir-Torre Syndrome and founder Mismatch Repair genes mutations: A long gone historical genetic challenge 205
Proteomic Analysis of PTCH1+/- Fibroblast Lysate and Conditioned Culture Media Isolated from the Skin of Healthy Subjects and Nevoid Basal Cell Carcinoma Syndrome Patients. 204
Alternative marker panel for Microsatellite Instability analysis in deection of contitutional MLH1 and MSH2 mutations. 203
Totale 28.913
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.476
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.384 0 0 0 0 0 0 428 567 224 537 289 339
2021/20223.306 260 412 347 182 73 176 175 184 360 238 553 346
2022/20232.776 357 345 210 236 329 383 59 255 316 51 133 102
2023/20241.862 86 90 129 174 383 193 193 216 53 48 100 197
2024/20256.728 193 63 92 405 1.297 1.049 455 429 707 365 677 996
2025/20267.470 637 376 887 1.800 2.756 810 204 0 0 0 0 0
Totale 38.251